复方氨基酸胶囊治疗维持性血液透析患者营养不良及钙磷代谢障碍的有效性和安全性

吴望舒, 王旻洲, 宋阿会, 赵冰茹, 鲁嘉越, 洪文凯, 顾乐怡, 谢可炜, 陆任华

Efficacy and safety of compound amino acid capsules in the treatment of malnutrition and calcium and phosphorus metabolism disorders in maintenance hemodialysis patients

WU Wangshu, WANG Minzhou, SONG Ahui, ZHAO Bingru, LU Jiayue, HONG Wenkai, GU Leyi, XIE Kewei, LU Renhua

表2 2组基线期实验室指标比较

Tab 2 Comparison of baseline parameters between the two groups

Item Treatment group (n=21) Control group (n=19) t/U value P value Albumin/(g·L-1) 35.20±3.05 37.47±2.19 102.000① 0.008 Prealbumin/(mg·L-1) 284.51±77.54 312.38±61.80 1.248 0.220 Hemoglobin/(g·L-1) 102.14±14.64 112.05±15.52 2.078 0.045 Ferritin/(μg·L-1) 454.50 (390.90) 247.70 (362.00) 127.000① 0.050 Serum phosphorus/(mmol·L-1) 2.09±0.35 1.87±0.38 125.500① 0.045 Serum calcium/(mmol·L-1) 1.77±0.51 2.21±0.25 68.500① 0.000 1,25-(OH)2-D3/(ng·mL-1) 14.59±5.03 13.87±6.45 0.382 0.705 iPTH/(pg·mL-1) 221.00 (248.45) 147.05 (194.33) 155.000① 0.338 hsCRP/(mg·L-1) 2.55 (8.81) 1.53 (2.19) 106.000① 0.018